Exploratory clinical trial of the new third line Helicobacter pylori eradication therapy using vonoprazan

Trial Profile

Exploratory clinical trial of the new third line Helicobacter pylori eradication therapy using vonoprazan

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 19 Oct 2016

At a glance

  • Drugs Vonoprazan (Primary) ; Amoxicillin; Sitafloxacin
  • Indications Helicobacter pylori infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Sep 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top